Seeing Is Believing
Currently out of the existing stock ratings of Julian Harrison, 169 are a BUY (94.94%), 8 are a HOLD (4.49%), 1 are a SELL (0.56%).
Analyst Julian Harrison, currently employed at BTIG, carries an average stock price target met ratio of 38.9% that have a potential upside of 59.35% achieved within 158 days.
Julian Harrison’s has documented 343 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on ORKA, Oruka Therapeutics at 13-Jul-2026.
Analyst best performing recommendations are on AVTE (AEROVATE THERAPEUTICS).
The best stock recommendation documented was for AVTE (AEROVATE THERAPEUTICS) at 12/6/2022. The price target of $27 was fulfilled within 6 days with a profit of $8.97 (49.75%) receiving and performance score of 82.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Dec-2024
$151
$14.89 (10.94%)
$119
14 days ago
(14-Jul-2026)
4/5 (80%)
$19.73 (15.03%)
179
Buy Since 09-Sep-2024
$145
$8.89 (6.53%)
$121
21 days ago
(07-Jul-2026)
8/9 (88.89%)
$4.15 (2.95%)
186
Buy Since 05-Nov-2024
$118
$-3.88 (-3.18%)
$86
2 months 22 days ago
(06-May-2026)
5/5 (100%)
$14.03 (13.49%)
122
Buy Since 25-Aug-2022
$137
$15.12 (12.41%)
$112
2 months 22 days ago
(06-May-2026)
18/19 (94.74%)
$33.03 (31.77%)
152
Buy Since 12-Dec-2024
$116
$-5.88 (-4.82%)
$74
3 months 21 days ago
(07-Apr-2026)
3/3 (100%)
$12.25 (11.81%)
122
Which stock is Julian Harrison is most bullish on?
Which stock is Julian Harrison is most reserved on?
What Year was the first public recommendation made by Julian Harrison?